Overview

Our research aims to expand the bounds of druggability for both fundamental and therapeutic discoveries. We achieve this through the development of covalent chemical tools and the leveraging of chemical proteomic technologies. We are particularly interested in developing chemical tools targeting proteins that drive cancers and immune disorders with unmet clinical needs. Our goal is to find chemical starting points to expand our understanding of fundamental biology and to develop next-generation therapeutics.

Positions

Education

Publications, Grants & Awards